Financial Commentary – December 2020
World markets soared on the news that Pfizer and BioNTech’s Covid-19 vaccine is 90% efficient (traditional flu jabs are around 50%). In addition, there are another 150 vaccines in development and 3,600 trials still being undertaken. It’s obviously great news although the organising of mammoth immunisation programmes means anything resembling normality is still some way…